EXELIXIS, INC. 8-K

What Happened

• On May 5, 2026, Exelixis, Inc. (EXEL) announced its financial results for the quarter ended April 3, 2026, via a press release (furnished as Exhibit 99.1 to the 8-K). The same announcement disclosed that the Board authorized up to an additional $750 million for repurchases of common stock, with the authorization effective through December 31, 2027.

Key Details

• Press release dated May 5, 2026, reporting quarterly results for the period ended April 3, 2026 (Exhibit 99.1).
• Board authorized up to $750 million in additional common stock repurchases, to be utilized by December 31, 2027.
• The press release is furnished with the Form 8-K and is incorporated by reference for the stated discussion; the company notes the exhibit is not “filed” for purposes of Section 18 of the Exchange Act or certain Securities Act liabilities.
• No other corporate actions (e.g., executive changes, mergers) were reported in this filing.

Why It Matters

• Quarterly results give investors updated information on Exelixis’ revenue and profitability trends; the press release is the primary disclosure of those metrics for the quarter ended April 3, 2026.
• The $750 million repurchase authorization is a material capital-allocation decision: share buybacks can reduce share count and potentially support earnings per share, and signal the Board’s view on capital use.
• Investors should review the detailed press release for the actual earnings and revenue figures, and monitor future disclosures for repurchase timing and execution details.